HSCS — HEART TEST LABORATORIES INC

Ownership history in UBS Group AG  ·  5 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in HEART TEST LABORATORIES INC (HSCS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 5,968 +3,343 +127.4% 0.00% $18K $3.09
2025 Q1 ADDED 2,625 +1,320 +101.1% 0.00% $7K $2.82
2024 Q4 ADDED 1,305 +624 +91.6% 0.00% $5K $3.82
2024 Q3 REDUCED 681 -5,715 -89.4% 0.00% $3K $4.85
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HSCS price (monthly, adj. close)

Other funds also holding HSCS

As of 2025 Q4 — sorted by position size

TFB Advisors LLC 3Y 0.03% Astoria Strategic Wealth, Inc. 3Y 0.01% DRW Securities, LLC 3Y 7Y 0.01% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% Federation des caisses Desjardins du Quebec 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0% BANK OF AMERICA CORP /DE/ 3Y 7Y 0.0%
← Back to UBS Group AG Holdings